For 25 years, Cogstate has proudly supported the cognitive measurement needs of biopharmaceutical companies, academic institutions, physicians, and patients around the world.
Read our StoryValid, highly sensitive and reliable digital solutions for cognitive measurement. Cogstate tests can detect subtle drug-related changes, are culture-neutral, designed for repeated administration, do not require expert neuropsychologist raters, and can rapidly be set-up across your sites.
Consistent administration and scoring of outcome measures via rater training and monitoring. Cogstate designs and delivers risk-based data quality programs that combine an understanding of your trial objectives with our knowledge of assessments and common rater error patterns.
The ability to create patient-centric, rapid-to-enrol clinical trials is critical to advancing therapeutic breakthroughs. Cogstate can help you implement a full suite of decentralized, remote testing solutions to reduce trial risk, improve data collection, and ease patient and site burden.
The Cogstate team of cognitive scientists is experienced with all aspects of clinical conduct, from study design to cognitive data interpretation. Our experts can provide drug development strategies, protocol design guidance, endpoint selection support, test design and development, and more.
Healthcare systems and patients need reliable tools to track cognitive decline. Cogstate supports the development and implementation of innovative solutions to meet growing healthcare system and community needs with tools to detect cognitive impairment and change.
Cogstate provides a digital cognitive testing system for the measurement of human cognition in your studies. Our well validated assessments are rapid, reliable, and have demonstrated sensitivity to even subtle changes across multiple cognitive domains.
Successful clinical trial evaluations of drug efficacy and safety hinge on having smart trial designs, highly sensitive tests, reliable ratings, and accurate data. Cogstate helps thousands of researchers worldwide make more informed decisions about their therapeutic drug candidates.